Volume
Well, if we have a few days with good volume. One might conclude tthat something is up.
Next resistance is 0,25
There is a new FDA administration change. FDA sentiment seems to have shift from protection to risk taking.
Fast tracking is problematic if you have a poor safety profile. This is the best safety profile ever.
I checked burn rate and it seems that TLN could have cash for until FEB 2010...
In the meantime, test data will help SP... and...
a) partnership deal
b) second bidder
c) white knight (none)
d) higher bid
e) final take over
Could end this story like a fairy tale.
Shigamabs is worthless
TLN-232, efficacy could be problem and targetting the right population for test could impact results
TLN-4601 is probably the best value driver here.